New gene variant linked to Parkinson’s disease found in people of African ancestry

A gene variant found almost exclusively in the genomes of people of African ancestry increases the risk of developing Parkinson’s disease, according to an international study of nearly 198,000 participants with this genetic background.

Verve Therapeutics, Lilly to advance gene editing programme

The collaboration will advance Verve Therapeutics’ in vivo gene editing programme targeting lipoprotein(a) to treat atherosclerotic cardiovascular disease. Credit: aodaodaodaod / Shutterstock.com. Verve Therapeutics and

June 15, 2023

PF-08046054 by Pfizer for Solid Tumor: Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Solid Tumor.

February 21, 2024

Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly

More than two dozen prominent health policy experts are urging the Biden administration to ensure that patient data collected about a new Alzheimer’s treatment is

July 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.